Astera Labs (ALAB) Projected to Post Quarterly Earnings on Tuesday

Astera Labs (NASDAQ:ALAB) is expected to issue its Q4 2025 results after the market closes on Tuesday, February 10th. Analysts expect Astera Labs to post earnings of $0.51 per share and revenue of $249.4620 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 4:30 PM ET.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same period in the prior year, the company earned $0.23 earnings per share. The company’s revenue was up 103.9% compared to the same quarter last year. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Price Performance

Astera Labs stock opened at $152.44 on Tuesday. The stock has a market capitalization of $25.75 billion, a PE ratio of 137.33, a price-to-earnings-growth ratio of 2.05 and a beta of 1.51. Astera Labs has a 12 month low of $47.13 and a 12 month high of $262.90. The business has a 50 day simple moving average of $164.08 and a 200-day simple moving average of $172.65.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 576,936 shares of company stock valued at $87,409,540 over the last three months. Insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently modified their holdings of the stock. Wexford Capital LP acquired a new stake in Astera Labs in the third quarter valued at approximately $39,000. National Bank of Canada FI lifted its holdings in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Astera Labs by 459.3% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 330 shares of the company’s stock valued at $65,000 after acquiring an additional 271 shares in the last quarter. Diversify Wealth Management LLC purchased a new stake in shares of Astera Labs during the second quarter worth about $106,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Astera Labs in the third quarter worth about $154,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALAB. Royal Bank Of Canada assumed coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $190.63.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.